Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

AstraZeneca
Boehringer Ingelheim
Colorcon
Medtronic
Johnson and Johnson
Dow

Last Updated: December 8, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 016909

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

NDA 016909 describes LIDEX, which is a drug marketed by Cnty Line Pharms and is included in three NDAs. It is available from two suppliers. Additional details are available on the LIDEX profile page.

The generic ingredient in LIDEX is fluocinonide. There are nine drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the fluocinonide profile page.
Summary for 016909
Tradename:LIDEX
Applicant:Cnty Line Pharms
Ingredient:fluocinonide
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 016909
Medical Subject Heading (MeSH) Categories for 016909
Suppliers and Packaging for NDA: 016909
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LIDEX fluocinonide OINTMENT;TOPICAL 016909 NDA Alvogen Inc. 47781-569 47781-569-26 1 TUBE in 1 CARTON (47781-569-26) > 60 g in 1 TUBE
LIDEX fluocinonide OINTMENT;TOPICAL 016909 NDA Alvogen Inc. 47781-569 47781-569-72 1 TUBE in 1 CARTON (47781-569-72) > 15 g in 1 TUBE
Paragraph IV (Patent) Challenges for 016909
Tradename Dosage Ingredient NDA Submissiondate
LIDEX OINTMENT;TOPICAL fluocinonide 016909

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:OINTMENT;TOPICALStrength0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Harvard Business School
Merck
McKinsey
Boehringer Ingelheim
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.